ao-xue
2.Effects of Di-ao-xin-xue-kang on serum serotoin and plasma thromboxane B_2 in myocardial ischemia reperfusion injury dogs
3.Thirty-four patients (M 19, F 15; age 61 ?9a) with angina pectoris were treated with Di-ao-xin-xue-kang capsule 0. 2 g, tid,Pox12wk.
4.Forty-six patients(M30,F16;age 57± s11 a) with coronary heart disease were treated with DI-ao-xin-xue-kang 200 mg po tid for 4-8 wk.
5.Di-ao-xin-xue-kang(200 mg,tid,po)was used to treat 132 patients with various arrhythmias (M 79,F 53;age 54± s6 a) for 60 d.
6.Effect of Di-ao-xin-xue-kang on 64 patients(M 46,F 18;age 56±s 6 a) with angina pectoris and changes of their nailfold microcirculation before and after therapy were observed.
7.Thirty patients with cerebral infarction(M17,F13;age 63±s 17 a) and 37 patients with vertebrobasilar arterial insufficiency(M18,F19;age 61±9 a) were treated with Di-ao-xin-xue-kang(DAXXK)200 mg,po,tid for 30 d.
